Device Trial Radar · NCT07286890
Getinge's Beating Heart Product Family Post-Market Clinical Follow-up (PMCF) Study
Last checked: Nov 20, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Mar 4, 2026
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Maquet CardiovascularNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 16, 2025
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This observational study aims to collect data on the performance and safety of Getinge's Beating Heart products used during open-heart coronary artery bypass graft surgery. The surgery and the use of the study devices will be done according to the standard of care. Participants will not be required to undergo any study-specific procedures, and information will be collected only until hospital discharge following the surgery.
Conditions
- Off Pump Coronary Artery Bypass Surgery
Interventions
Vacuum Stabilizer SystemDevice
Isolates and provides local immobilization of the target vessel while performing the distal anastomosis on a beating heart.
Vacuum Positioner SystemDevice
Positions the heart and exposes the coronary artery(ies) when performing the distal anastomosis on a beating heart.
Blower/MisterDevice
Reduces blood in the operative field to improve visibility while performing an anastomosis on a beating heart.
Proximal Seal SystemDevice
Proximal anastomotic seal technology allows for clampless hemostasis during proximal anastomosis when performing Coronary Artery Bypass Graft (CABG) procedures.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of device-related adverse eventsTime frame: Time period from procedure through study completion, an average of 7 days
- Incidence of device-related serious adverse eventsTime frame: Time period from procedure through study completion, an average of 7 days
- Incidence of technical successTime frame: Perioperative/Periprocedural
Locations
7 sites in 3 countries. Site status is shown where the registry gives one.
St. Joseph's Medical Center Stockton
Stockton, California · Recruiting
Aspirus Medical Group
Wausau, Wisconsin · Recruiting
University Medical Center Rostock
Rostock, Germany · Recruiting
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.